SRC family kinase inhibitor
Catalog No. S19-900B
Catalog No. | Pack Size | Price (USD) | |
---|---|---|---|
S19-900B-05 | 5 mg | $105 | |
S19-900B-25 | 25 mg | $390 | |
S19-900B-BULK | BULK | Contact Us |
Overview:
Potent and selective Src family kinase inhibitor. Inhibits Lck (IC50=4 nM), Fyn (IC50=5 nM), and Hck (IC50=5 nM).Shows weaker inhibition of EGFR (IC50=480 nM) and no inhibition of ZAP-70 (IC50=100 uM) and JAK2 (IC50=50 uM). Useful for probing the involvement of Src family tyrosine kinases in cellular signaling.
References:
1. F. Carlomagno et al.; J. Clin. Endocrinol. Metab. 2003 8:1897
2. J.K. Chen et al.; J Biol Chem. 2000 275:13789
3. M. Yoshizumi et al.; J. Biol. Chem. 2000 275:11706
4. J.H. Hanke et al.; J. Biol. Chem. 1996 271:695
CAS Registry Number:
172889-27-9
Molecular Formula:
C15H16ClN5
Appearance:
Off-white solid
Melting Point:
N/A
Molecular Weight:
301.8
Purity:
>98% (TLC); NMR (Conforms)
Solubilization:
May be dissolved in DMSO (25 mg/ml); or ethanol (3 mg/ml, warm)
Aliases:
3-(4-chlorophenyl) 1-(1,1-dimethylethyl)-1H-pyrazolo [3,4-d] pyrimidin-4-amine
Storage and Stability:
Store desiccated as supplied at -20oC for up to 2 years. Store stock solutions at -20oC for one month.
Molecular Structure:
There are no related publications available for this product.
Angiogenesis, Apoptosis/Autophagy, Cancer, Cytoplasmic Tyrosine Kinases, ERK/MAPK Pathway, Inflammation, Invasion/Metastasis, JAK/STAT Pathway
STAY CONNECTED
Fax: 1-604-232-4601